Human genes are remarkably flexible. Through alternative splicing, a single gene can generate multiple messenger RNA molecules, each potentially encoding a distinct protein isoform. These variants may differ by only a short sequence segment, yet those small changes can alter where a protein travels inside a cell, which molecules it interacts with, or whether it activates or suppresses a signaling pathway. More than 95 percent of human multi-exon genes are estimated to undergo alternative splicing, making isoform diversity a defining feature of the human proteome.

This complexity has created a major challenge for functional genomics. Sequencing projects have identified millions of transcript isoforms, but experimentally testing the function of every variant would require enormous amounts of time and resources. Many existing computational tools attempt to infer function from protein sequence similarity, gene-level annotations, or known molecular interactions. While these approaches can be powerful, they may overlook the precise splicing events that distinguish one isoform from another, especially when closely related proteins have highly similar sequences.

SpliceEM was developed to address that limitation by combining several biological data types within a single computational framework. The system integrates protein and transcript sequences, Gene Ontology annotations, alternative splicing events, and molecular interaction information. Instead of representing an isoform as an isolated sequence, it places the isoform within a heterogeneous biological graph, a network in which different kinds of entities and relationships can be modeled simultaneously. Isoforms, genes, functional terms, and splicing events can therefore contribute to the same prediction process.

At the core of the framework is a Heterogeneous Graph Transformer, or HGT. This type of neural network is designed to pass information across networks containing multiple node and edge types. In SpliceEM, message passing allows the model to learn how sequence features relate to splicing patterns, how splicing events connect to functional annotations, and how isoforms fit into broader molecular interaction networks. The result is an embedding, or numerical representation, intended to capture the biological characteristics that make one isoform functionally distinct from another.

The researchers also incorporated a teacher-student optimization strategy based on exponential moving averages and multiple-instance learning. In this arrangement, a teacher model provides stable guidance to a student model as the system learns from partially labeled biological data. Multiple-instance learning is particularly useful when annotations are available at the gene level but not for every individual isoform. SpliceEM uses gene-masked asymmetric loss to reduce the risk that the model simply copies gene-level labels onto all transcripts. Hierarchical constraints further encourage predictions to remain consistent with the structured relationships among biological functions.

Across several benchmark datasets, the study reports that adding alternative splicing information substantially improved protein isoform function prediction. The gains were especially notable for functions with limited experimental annotations, a setting in which conventional prediction methods often struggle. By explicitly incorporating splicing events, the framework was better able to separate isoforms originating from the same gene and identify functional differences that may be invisible to sequence-similarity approaches alone.

The model’s learned representations also offered clues about the biology of isoform diversification. Skipped exons and alternative first exons emerged as especially influential event types. Exon skipping can remove a segment of the resulting protein and potentially alter its interaction surfaces or regulatory properties. Alternative first exons may change the beginning of a transcript, affecting protein targeting, cellular localization, or the regulation of transcription itself. In the study, these events were linked to functional divergence and showed strong associations with cancer-related signaling systems, including the MAPK and JAK–STAT pathways.

Those pathways are central to how cells respond to growth signals, inflammation, stress, and developmental cues. Disruptions in their regulation are common in cancer, where abnormal signaling can promote uncontrolled proliferation or help tumor cells evade normal cellular restraints. The findings suggest that relatively localized changes in RNA processing may contribute to much broader changes in cellular behavior. They also reinforce the idea that disease-associated biology may be missed when researchers analyze genes as single units rather than examining the individual isoforms a gene produces.

SpliceEM remains a computational framework, and its newly predicted functions will require experimental validation before they can be considered established biological facts. Nevertheless, the study points toward a more detailed approach to genome interpretation—one that connects RNA processing directly to protein function. As long-read sequencing, single-cell transcriptomics, and disease genomics continue to reveal increasingly complex patterns of isoform usage, tools capable of interpreting this diversity could become valuable for studying disease mechanisms, discovering biomarkers, and prioritizing targets for laboratory investigation. The broader message is clear: alternative splicing does not merely expand the number of transcripts in a cell; it may provide a functional language that helps explain how one gene can support many distinct biological outcomes.

Subject of Research: Computational prediction of protein isoform functions and the biological role of alternative splicing.

Article Title: Isoform function prediction via knowledge distillation from alternative splicing

Web References: https://doi.org/10.70401/cbm.2026.0019; Computational Biomedicine

References: Gu T and Wang J, “Isoform function prediction via knowledge distillation from alternative splicing,” Computational Biomedicine, DOI: 10.70401/cbm.2026.0019.

Image Credits: © Gu T, Wang J, 2026. Open Access under a Creative Commons Attribution 4.0 International License.

Keywords: alternative splicing, protein isoforms, SpliceEM, isoform function prediction, heterogeneous graph transformer, knowledge distillation, multi-instance learning, computational biology, MAPK signaling, JAK–STAT signaling, cancer genomics

HELIX is not just another machine learning tool; it represents a comprehensive integration of pre-mRNA sequences with RNA-binding protein (RBP) expression profiles. RNA-binding proteins are key regulators that influence splicing decisions by interacting with specific RNA motifs, yet their impact varies dramatically across tissue types and physiological or pathological states. By jointly modeling these layers of regulatory information, HELIX captures the dynamic, context-dependent regulation of RNA splicing with unprecedented accuracy. This holistic approach allows it to go beyond traditional sequence-based prediction models which often fail to account for the functional relevance of RBPs.

One of the most notable innovations in HELIX’s development is the strategic use of both short-read and long-read RNA sequencing data during the training phase. Short-read RNA-seq data has been the workhorse of transcriptomic studies but is limited in resolving full-length isoforms. In contrast, long-read sequencing technologies provide a more complete snapshot of transcript architectures, essential for accurate isoform-level analysis. By harmonizing these complementary data types, HELIX achieves a more refined and reliable prediction of differential splicing events and isoform diversity, solving a major bottleneck in transcriptomics research.

Comparative benchmarking against existing splicing prediction models revealed that HELIX consistently outperforms earlier approaches. This performance extends across various prediction tasks, including the identification of differential alternative splicing events, the estimation of splicing strength at highly regulated splice sites, and the quantification of isoform usage. Such a multifaceted capability is essential because splicing regulation occurs at multiple layers, and dysregulation can manifest in subtle yet critical alterations in isoform expression and splicing efficiency.

Beyond mere prediction, HELIX offers a powerful platform for systematically uncovering tissue-specific splicing quantitative trait loci (sQTLs). sQTLs are genomic variants that associate statistically with particular splicing patterns and can illuminate genetic underpinnings of complex traits and diseases. The ability to identify these loci comprehensively enables researchers to link splicing variation directly to functional consequences, bridging the gap between genotype and phenotype in human populations and model organisms.

The application of HELIX to clinical cohorts further underscores its potential translational impact. In studies involving colon cancer patient samples, the model successfully predicted patient-specific splicing dysregulation. More importantly, it provided quantitative attribution, deconvolving the effects of genetic variants versus aberrant RNA-binding protein expression. This dual attribution is critical for understanding the molecular basis of oncogenic splicing alterations and may inform personalized therapeutic strategies targeting splicing regulation or RBP function.

Furthermore, the adaptability of HELIX extends to single-cell RNA sequencing (scRNA-seq), a domain that has transformed cell biology by resolving transcriptional heterogeneity at unparalleled resolution. Through transfer learning techniques, the model can be fine-tuned to predict cell-type-specific isoforms from single-cell data, circumventing the technical challenges of splicing analysis in low-input and noisy single-cell datasets. This capability opens new avenues for exploring splicing regulation in development, immune responses, and disease at the cellular level.

Technically, HELIX employs a hierarchical deep learning architecture tailored to the spatiotemporal complexity of splicing regulation. At its core, the model integrates sequence features from pre-mRNA with contextual data from RBP expression patterns, encoding both local and global regulatory cues. The hierarchical design enables layered abstraction, capturing intricate interactions between sequence motifs and protein regulators that define cell- and tissue-specific splicing decisions. This intricate computational framework exemplifies how advanced deep learning techniques are revolutionizing the life sciences by harnessing biological complexity.

The greater precision in predicting splicing strength at highly regulated splice sites achieved by HELIX is particularly valuable. Such splice sites often act as molecular switch points critical for gene expression regulation in development and disease. By providing quantitative predictions of splice site activity, HELIX offers insights into the molecular grammar that governs splice site recognition and usage, potentially guiding the design of synthetic splicing modulators or RNA therapeutics.

The development of HELIX also signals a growing trend in bioinformatics toward integrative multi-omics modeling. By incorporating diverse data modalities—sequence, protein expression, genetic variation—the model embodies a systems biology approach necessary to grapple with multifactorial molecular processes. This integrative paradigm is crucial as biomedical data generation continues to accelerate, demanding scalable computational models capable of extracting actionable insights from complex biological networks.

Importantly, HELIX’s scalability ensures it can be applied across a broad range of biological questions and datasets, from fundamental research to clinical applications. Its ability to adapt to emerging sequencing technologies and experimental contexts highlights the forward-looking design of the framework. As single-cell technologies and long-read sequencing become increasingly routine, tools like HELIX will be indispensable for unraveling the nuanced regulatory landscapes shaping transcriptomes.

While the promise of HELIX is immense, challenges remain. The model’s performance inherently depends on the quality and diversity of input datasets, including accurate RBP expression profiles and comprehensive sequencing data. Ongoing efforts to generate high-resolution, condition-specific datasets will further enhance HELIX’s predictive power. Additionally, integrating epigenetic and chromatin interaction data could deepen understanding of splicing regulation’s upstream control mechanisms.

The broader impact of HELIX extends to many fields, including developmental biology, neurogenetics, immunology, and cancer research. Its ability to predict and interpret splicing dynamics will facilitate the discovery of novel therapeutic targets, biomarkers, and molecular mechanisms underlying diseases caused by splicing dysregulation. As RNA-based therapies continue to expand, understanding context-dependent splicing regulation becomes a key medical frontier.

In conclusion, HELIX represents a powerful and versatile computational model that advances our capacity to decode the complex regulation of RNA splicing and isoform usage. By bridging sequence information with protein regulator expression and leveraging multi-platform sequencing data, it achieves unprecedented accuracy in predicting context-specific splicing events. Its successful application across population genetics, cancer biology, and single-cell transcriptomics showcases its broad utility and transformative potential for biomedical research. HELIX is set to become a foundational tool in the era of precision transcriptomics, enabling deeper insights into the molecular language of life and disease.

Subject of Research: RNA splicing regulation; context-dependent alternative splicing; isoform prediction; RNA-binding proteins; deep learning applications in transcriptomics.

Article Title: HELIX: a scalable model for predicting context-dependent regulation of RNA splicing and isoform usage.

Article References:
Zhou, Z., Wu, B., Zheng, X. et al. HELIX: a scalable model for predicting context-dependent regulation of RNA splicing and isoform usage. Nat Comput Sci (2026). https://doi.org/10.1038/s43588-026-00988-w

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s43588-026-00988-w

Proteins, fundamental biomolecules that govern life itself, are being decoded with unprecedented accuracy. The advent of sophisticated models capable of predicting protein structures has dismantled long-standing barriers in structural biology. Beyond predicting static structures, these models offer insights into dynamic conformational changes and functional annotations, illuminating pathways previously shrouded in complexity. This represents not just an incremental advance but a paradigm shift, as the conventional methods of experimental elucidation are complemented and, in some cases, superseded by computational foresight.

In parallel, the interpretation of genomic regulation is undergoing a renaissance driven by deep learning. Molecular biology’s age-old enigma—how the genome’s regulatory elements precisely control gene expression—finds new clarity through models that can digest single-cell expression profiles and chromatin accessibility data. By reconstructing the multilayered regulatory networks, these models enable a more holistic understanding of cellular behavior and disease states, opening avenues for targeted therapeutics and personalized medicine that leverage a patient’s unique molecular signature.

Perhaps most striking is the revolution in de novo molecular design and synthesis planning, which is redefining medicinal chemistry and materials science. Large language models (LLMs) harness chemical languages such as SMILES strings, empowering researchers to invent novel molecules with desired properties while simultaneously charting feasible synthetic routes. This synergy not only accelerates the traditionally lengthy and costly drug discovery pipelines but also pushes the boundaries of creativity in molecular innovation, contributing to sustainable chemistry and efficient material development.

Such advancements signify an overarching trend toward unified, multimodal frameworks that reconcile diverse datasets into integrated foundation models. These architectures do not simply operate in silos of protein sequences or chemical structures but instead amalgamate heterogeneous data types—genomic, transcriptomic, proteomic, and chemical information—yielding comprehensive representations that imbue models with robustness and versatility. This integration signals a new era where biological and chemical phenomena are decoded through a shared computational prism.

Yet, this burgeoning field grapples with critical challenges. Central among them is the alignment of model capabilities with established biological and chemical knowledge. The mere ability to ingest large datasets is insufficient; the learning process necessitates embedding fundamental domain insights as priors—guiding the models to respect the axioms and constraints inherent in natural systems. This convergence of empirical knowledge and computational prowess is essential to ensure both scientific rigor and practical utility.

Complementing this is the vital need for standardized benchmarks that enable rigorous model evaluation. Without universally accepted metrics and datasets, comparing model performance becomes an exercise fraught with inconsistency, stymieing progress and reproducibility. Such benchmarks are crucial not only for validating predictions but also for facilitating iterative improvements, fostering an environment of transparent innovation in the bio/chemical machine learning community.

Concurrently, interpretability remains a frontier challenge. While LLMs exhibit remarkable predictive and generative capabilities, understanding the rationale behind their outputs is imperative for building trust among biologists and chemists. Deciphering the decision-making processes within these models will bridge the gap between computational predictions and experimental validation, nurturing confidence and accelerating adoption in practical settings.

Looking forward, the trajectory of bio/chemical LLMs is oriented toward more interactive, agentic systems—intelligent assistants endowed with the ability to participate actively in hypothesis generation and experimental design. These agents will not only process input data but engage cognitively with scientists, suggesting experiments, identifying anomalies, and even driving discovery cycles autonomously. Such developments promise to revolutionize the design–build–test–learn paradigm, compressing timelines and amplifying scientific creativity.

The implications of these advancements ripple across multiple sectors. In pharmaceuticals, accelerated drug discovery could bring novel therapeutics to market faster, addressing unmet medical needs with precision-tailored molecules. In agriculture, improved understanding of plant regulatory networks may lead to resilient crops adapted to changing climates. Environmental science stands to benefit through novel catalysts and materials designed to remediate pollution or optimize renewable energy technologies—all underpinned by these versatile computational frameworks.

Nevertheless, this brave new world demands sustained interdisciplinary collaboration. Harnessing the full potential of bio/chemical LLMs requires chemists, biologists, data scientists, and AI specialists to converge, exchanging insights and forging protocols that balance innovation with safety and ethical considerations. This collective intelligence will be paramount in steering the field away from pitfalls and towards responsible, impactful applications.

Moreover, the field must remain vigilant about data quality and representation biases. The heterogeneity and noise inherent in biological and chemical datasets pose risks of skewed learning and misleading predictions. Proactive strategies, such as curating diverse and representative datasets alongside robust validation techniques, are indispensable pillars supporting the integrity of these transformative models.

Beyond immediate applications, these technological strides hint at a profound reconceptualization of molecular sciences. The very notion of molecules as “languages” redefines how scientists think about chemical and biological information. This linguistic metaphor offers a conceptual framework that unifies disparate realms—from nucleotide sequences to synthetic polymers—under a comprehensive computational umbrella, fostering a holistic understanding of life and matter.

Ultimately, the rise of large language models in biology and chemistry embodies a fusion of human ingenuity and machine intelligence. As these models mature into foundational platforms, they promise to accelerate discovery cycles, inform experimental strategies, and inspire innovations beyond current imagination. The future of molecular science is not merely one of accumulation but of integration and synthesis—where data, knowledge, and computational creativity converge to unlock the secrets of life and matter at unprecedented scales and depths.

Subject of Research: The integration of large language models in biology and chemistry for molecular representation, prediction, and design.

Article Title: A survey on large language models in biology and chemistry.

Article References:
Ashyrmamatov, I., Gwak, S.J., Jin, S.Y. et al. A survey on large language models in biology and chemistry. Exp Mol Med (2026). https://doi.org/10.1038/s12276-025-01583-1

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s12276-025-01583-1

The implications of this research are profound, particularly in the context of bioterrorism and infectious disease control. Bacillus anthracis is notorious for its bioweapon potential, and a thorough understanding of its genomic blueprint could aid in developing more effective vaccines and therapeutic strategies. By leveraging machine learning algorithms, the researchers aimed to dissect the genomic data at an unprecedented scale, extracting meaningful patterns that could reveal insights into the organism’s adaptability to various environments and hosts.

Machine learning techniques have transformed the paradigm of data analysis, enabling researchers to process vast amounts of genomic information that would be otherwise insurmountable. This research employed these techniques to integrate multiple genomic sequences and characterize the pan-genome of Bacillus anthracis. Pan-genomic analyses offer a new lens through which scientists can view genetic variations among pathogens, elucidating how certain strains might evolve greater virulence or resistance to treatment.

One pivotal finding of this research is the discovery of unique genomic features that contribute to the virulence of specific Bacillus anthracis strains. By comparing genomic sequences from different strains, researchers identified genes that are closely associated with virulence. These genetic markers could potentially serve as targets for vaccine development or therapeutic interventions. Understanding which strains are more virulent allows health authorities to establish more effective monitoring systems and response protocols, particularly in regions prone to anthrax outbreaks.

In addition to identifying virulence factors, the study’s machine learning approach allows for a predictive modeling of how Bacillus anthracis might adapt in response to various selection pressures, whether they originate from host immune responses or environmental factors. Predictive models indicate that as our strategies for combating this pathogen evolve, so will the pathogen itself. This gives rise to the critical need for continuous surveillance of Bacillus anthracis strains, ensuring we stay one step ahead in the arms race against infectious diseases.

The comparative analysis aspect of the research provided insights into how genetic exchange occurs among different strains of Bacillus anthracis. Horizontal gene transfer is a significant mechanism by which bacteria enhance their survival and adaptation. The findings suggest that environmental factors or interactions with other bacterial species could facilitate the transfer of virulence genes, further complicating our efforts to manage this pathogen. This emphasizes the importance of understanding the ecological niches that harbor Bacillus anthracis, as they may serve as reservoirs for genomic variation.

Furthermore, the research highlights the role of the environment in shaping genomic fitness and adaptability. It is evident that factors such as soil composition, temperature fluctuations, and the presence of other microorganisms can significantly influence the genetic evolution of Bacillus anthracis. Exploring these environmental interactions provides a holistic view of how the bacterium thrives and poses risks to both animal and human health, highlighting the need for interdisciplinary approaches in studying infectious diseases.

The potential for genomic surveillance emerges as a critical recommendation from this study. The ability to track genetic changes over time can provide actionable intelligence for public health officials and policymakers. Implementing real-time genomic surveillance could enhance our response capabilities, enabling quicker interventions during anthrax outbreaks. This proactive approach has the potential to mitigate public health risks before they escalate, ultimately saving lives and resources.

Ethical considerations also come to the forefront when discussing research involving dangerous pathogens. The dual-use nature of such studies, where findings can be applied for both beneficial and harmful purposes, necessitates a careful examination of how genomic data is utilized. As researchers unlock the genetic secrets of Bacillus anthracis, they must remain vigilant about the implications their work may have on biosafety and biosecurity.

In conclusion, the research spearheaded by Y.S. Sekar and colleagues not only enhances our understanding of Bacillus anthracis but also sets the stage for future studies exploring the genomic landscapes of other pathogens. By marrying machine learning with comparative genomics, researchers are paving the way for innovative approaches in infectious disease control and treatment. The comprehensive insights gleaned from this study underscore the importance of continual research, vigilance, and the integration of advanced analytical tools in responding to ongoing and emerging threats from infectious diseases.

As the scientific community eagerly anticipates more findings stemming from this innovative work, it is imperative that ongoing research remains transparent and collaborative. In this age of rapid technological advancement, harnessing the power of genomic research in a responsible manner could redefine our strategies not only against Bacillus anthracis but also myriad other infectious agents that continue to challenge public health globally.

Subject of Research: Genomic adaptability and virulence of Bacillus anthracis

Article Title: Genomic adaptability and virulence of Bacillus anthracis: a machine learning-based pan-genome and comparative analysis

Article References: Sekar, Y.S., Chellapandi, P., Suresh, K.P. et al. Genomic adaptability and virulence of Bacillus anthracis: a machine learning-based pan-genome and comparative analysis.
BMC Genomics (2026). https://doi.org/10.1186/s12864-025-12348-5

Image Credits: AI Generated

DOI:

Keywords: Anthrax, Bacillus anthracis, Genomic Adaptability, Machine Learning, Pan-genomic Analysis, Virulence Factors, Infectious Disease Control, Horizontal Gene Transfer, Public Health.

Cancer has long been recognized as a disease rooted in genetic chaos. Mutations, chromosomal breaks, and irregular rearrangements precipitate a breakdown in normal cellular function, leading cells to evade growth controls and proliferate uncontrollably. For well over a century, scientists have hypothesized the critical role of chromosomal abnormalities in this process, dating back to Theodor Boveri’s early microscopy observations in the early 1900s. Yet, capturing these chromosomal aberrations in living cell populations has remained a formidable challenge. Cells harboring such defects are typically scant in number and prone to elimination through natural selection mechanisms, rendering their identification akin to finding needles in a cellular haystack.

MAGIC revolutionizes this pursuit by automating what was previously a labor-intensive and error-prone task. It deploys a sophisticated machine learning model trained on manually annotated images to recognize a telltale cellular feature known as the micronucleus. These diminutive, DNA-containing compartments detach from the main nucleus and are a definitive sign of underlying chromosomal instability. By effectively performing a digital version of laser tag, MAGIC directs a laser beam to “tag” these micronucleated cells through a photoconvertible dye. This dye alters its fluorescence upon exposure to targeted light, enabling precise marking of those cells for subsequent isolation and study without disrupting their viability.

The ramifications of this technology are profound. Through high-throughput automated microscopy paired with AI-driven image analysis, MAGIC can analyze tens of thousands of cells within a single day, a feat unattainable by manual microscopy. This scale facilitates robust statistical assessments of the frequency and causes of chromosomal abnormalities, providing a window into the cell division dynamics that foster genomic instability. Early usage of MAGIC has revealed that over 10% of cell divisions result in spontaneous chromosomal errors. Strikingly, this incidence nearly doubles in cells where the tumor suppressor gene p53 is mutated—a frequent mutation in human cancers—highlighting the gene’s pivotal role in maintaining chromosomal fidelity.

Furthermore, MAGIC’s insights extend beyond mere rate quantification. By correlating micronucleus presence with locations of DNA double-strand breaks, it sheds light on the genomic landscapes susceptible to instability. This coupling of imaging and genomics offers a multidimensional perspective crucial for unraveling the mechanistic underpinnings that drive chromosomal missegregation and rearrangement during mitosis. These insights could illuminate pathways leading to metastasis, drug resistance, and tumor relapse, which are tightly linked to chromosomal instability.

The development of MAGIC epitomizes interdisciplinary collaboration, uniting expertise across computer vision, robotic automation, genomics, and microscopy. The core team from EMBL Heidelberg worked closely with the Advanced Light Microscopy Facility and partners at the German Cancer Research Centre, among others, to engineer this powerful platform. Their efforts exemplify how melding cutting-edge AI with biological research can surmount previously insurmountable obstacles in cell biology.

Looking ahead, the flexibility of MAGIC promises broad applicability. Although trained to detect micronuclei in this inaugural study, the underlying machine learning algorithms can theoretically be adapted to identify diverse cellular features indicative of pathogenic or physiological states. Hence, this platform could become an indispensable tool across numerous biological disciplines, from neuroscience to immunology, wherever visual cell phenotyping and subsequent molecular characterization are needed.

Importantly, MAGIC is not merely a tool for cancer researchers; it represents a paradigm shift in how we perform single-cell analysis. By automating detection and marking at a cellular level in living populations, it bridges the gap between high-content imaging and genomic interrogation, enabling unprecedented resolution in studying cellular heterogeneity. This technological leap will expedite discovery and, ultimately, foster new diagnostic and therapeutic strategies targeting chromosomal instability’s root causes.

In essence, MAGIC embodies the convergence of artificial intelligence and biological microscopy, overcoming longstanding technical hurdles in cancer biology. By illuminating the origins and dynamics of chromosomal instability with unprecedented clarity and throughput, it provides a vital new lens through which to explore cancer’s earliest and most consequential genetic derangements. As malignancies continue to challenge human health globally, such innovations hold promise not only to deepen scientific understanding but also to spur development of interventions that intercept cancer at its genomic inception.

European Molecular Biology Laboratory’s senior scientist Jan Korbel, who led the study published in Nature, emphasizes that this technology aligns with the cutting edge of AI-driven biology: “Our system can be trained on almost any visually distinguishable cellular trait, opening new vistas for biological exploration and discovery.” This union of machine learning, robotics, and genomics stands as a testament to the transformative potential of interdisciplinary science in tackling humanity’s most daunting diseases.

Subject of Research: Cells
Article Title: Origins of chromosome instability unveiled by coupled imaging and genomics
News Publication Date: 29-Oct-2025
Web References: DOI: 10.1038/s41586-025-09632-5
Image Credits: Daniela Velasco/EMBL
Keywords: Molecular biology

Efflux proteins are integral components of the bacterial cellular machinery, responsible for exporting harmful substances, including antibiotics. This novel study focuses on the important role of these proteins in microbial resistance and their implications for public health. The ability of bacteria to thrive despite the presence of antibiotics is primarily attributed to these efflux systems, making their study paramount for developing future therapeutic approaches.

The researchers utilized an advanced computational framework, emphasizing the power of machine learning to sift through genomic data and discern patterns. Traditional methods of protein identification often rely on sequence conservation; however, the innovative stacked ensemble classifier aggregates multiple models, enhancing accuracy and sensitivity in detecting efflux proteins. This approach underscores the shift towards data-driven methodologies in understanding complex biological systems.

By employing various classifiers within the ensemble structure, the researchers were able to refine the identification process, leading to an impressive improvement in prediction outcomes. The foundational premise of the study involves the integration of various modeling strategies, utilizing both supervised and unsupervised learning techniques. This multifaceted approach not only broadens the scope of effective detection but also establishes a new benchmark for future studies in genomics.

Crucially, this research has demonstrated that the utilization of sequence information can yield significant insights into the property and behavior of prokaryotic efflux proteins. By harnessing machine learning tools, Wang et al. adeptly navigated large datasets, synthesizing findings that might have been obscured by conventional analytical methods. Such advancements highlight the indispensability of computational tools in modern biological research.

The study reveals that the ensemble model surpasses previous efforts in terms of both robustness and predictive performance. This innovation has substantial implications for the field of antibiotic resistance, as understanding the genetic makeup of efflux systems is instrumental in devising strategies to counteract their effects. With rising concerns about multidrug-resistant strains, this research represents a crucial step towards enhanced biosurveillance of bacterial pathogens.

Moreover, the findings highlight a significant leap forward in understanding the evolution of efflux proteins. By analyzing phylogenetic patterns, the researchers were able to ascertain how these proteins have developed in various bacterial lineages. This evolutionary perspective is essential, especially when considering the adaptive strategies bacteria employ in response to environmental pressures, including antibiotic exposure.

As part of the study, Wang and the team identified several new candidates for prokaryotic efflux proteins. These discoveries are instrumental for future experimental validation and may provide the basis for new therapeutic targets. By identifying these candidates, the researchers not only enrich our genomic databases but also ignite a pathway for subsequent investigations aimed at countering antibiotic resistance more effectively.

The comprehensive dataset incorporated in this study is a testament to the extensive information that machine learning can glean from genomic sequences. With the rising need for rapid identification processes in microbiology, this research paves the way for developing not only more precise detection systems but also enhancing diagnostic capabilities within clinical settings. The implications extend beyond academia; they directly affect public health policies and antibiotic stewardship programs.

Reflecting on potential applications, the implications of this research transcend academic laboratories. Hospitals and health organizations can leverage insights from this study to develop rapid assays for identifying resistant strains earlier in the treatment process. This early detection would enable clinicians to tailor antibiotic therapies more effectively, thus improving patient outcomes while also mitigating the spread of resistant infections.

Additionally, educational initiatives can draw from this study to emphasize the significance of computational biology in microbiology training. By integrating machine learning techniques into biological curricula, future researchers will be equipped with the necessary skills to tackle complex biological challenges. This intersection of computer science and biology fosters innovation and creativity among emerging scientists.

As the study was prepared for publication in BMC Genomics, it garnered interest from the global scientific community. The implications of Wang et al.’s research resonate beyond prokaryotic implications, urging a re-evaluation of classification systems in other biological realms as well. The successful application of a stacked ensemble classifier may inspire similar approaches in the identification and study of various biological entities, thus broadening the horizon of research possibilities.

In conclusion, this notable advancement in the identification of prokaryotic efflux proteins using a stacked ensemble classifier represents a vital stride in combating antibiotic resistance. As the fight against such infections intensifies, the insights garnered from this research pave the way for innovative interventions and renewed hope in the realm of microbial genomics. It is a poignant reminder that technology and biology, when fused, can yield transformative results that benefit humanity.

Subject of Research: Prokaryotic efflux proteins identification using a stacked ensemble classifier.

Article Title: A stacked ensemble classifier for the discovery of prokaryotic efflux proteins based on sequence information.

Article References:

Wang, Q., Yue, Q., Tao, Z. et al. A stacked ensemble classifier for the discovery of prokaryotic efflux proteins based on sequence information.
BMC Genomics 26, 851 (2025). https://doi.org/10.1186/s12864-025-12039-1

Image Credits: AI Generated

DOI: 10.1186/s12864-025-12039-1

Keywords: Prokaryotic efflux proteins, antibiotic resistance, stacked ensemble classifier, machine learning, genomic data, microbial genomics, drug resistance, classification systems.

The importance of improving genomic prediction in pigs cannot be understated, particularly as the demand for high-quality pork continues to rise globally. Traditional breeding methods often rely on phenotypic traits and simple pedigree information; however, this approach can be limiting given the complexities inherent in genetic traits. The researchers in this study have taken a novel approach by tapping into the power of existing genomic data from multiple pig populations. This integration houses a wealth of genetic information that, when analyzed collectively, can yield more robust predictive models.

In their method, the research team utilized advanced statistical frameworks and machine-learning algorithms to analyze the genomic data. They focused on markers associated with economically significant traits such as growth rate, feed efficiency, and disease resistance. Harnessing the power of artificial intelligence in conjunction with genomic data, this study sets a new precedent in how breeders can select for desirable traits in livestock. Moreover, the application of prior knowledge in genomics enhances the model’s accuracy, allowing for a more informed selection process.

To validate their predictive model, the researchers conducted comprehensive experiments across various genetic lines of pigs. By measuring the success of their predictions against actual phenotypic performances in real-world settings, they were able to fine-tune their algorithm and demonstrate its efficacy. This level of empirical validation is critical, as it ensures that the model is not merely theoretical but has practical applications that can directly benefit farmers and breeders.

The impact of this research extends beyond just pig breeding; it underscores a paradigm shift in how genetic information can be utilized across different livestock species. The integration of multi-population data is a game-changer, offering insights that could be applicable to cattle, sheep, and poultry as well. As agricultural practices evolve in an increasingly technological world, these strategies will be essential in meeting the challenges posed by global food security and sustainability.

Another noteworthy aspect of this study is the emphasis on collaborative efforts in genomic research. The researchers acknowledged contributions from various institutions, highlighting the interconnected nature of scientific inquiry in today’s world. Such collaborations not only pool resources and expertise but also foster innovation through diverse perspectives. The study thus serves as a model for future research endeavors in genomics, encouraging researchers to bridge gaps between populations and disciplines.

As noted by the authors, one of the overarching goals of improving genomic prediction is to streamline breeding programs for efficiency and cost-effectiveness. Producers standing to benefit from reduced production costs and improved animal welfare indicate the practical implications of genomic advancements. With the integration of predictive analytics, pig breeders can make informed decisions, minimizing guesswork and maximizing their returns on investment.

Moreover, the challenges of climate change and health crises in livestock populations are presenting new hurdles that require innovative solutions. The insights gained from sophisticated genomic predictions can help breeders develop pigs that are more resilient to disease and adaptable to changing environmental conditions. This foresight could bolster the health of livestock herds, ultimately reducing the need for antibiotics and promoting more sustainable farming practices.

As detailed in the study, the wealth of data utilized for multi-population genomic prediction was sourced from public databases and collaborative research initiatives. This transparency enables the wider scientific community to engage with the findings, potentially leading to further advancements and refinements in genomic research. By making such data accessible, researchers pave the way for a more open and collaborative approach to genetic studies.

The implications of improving genomic prediction in pigs resonate on a global scale. As countries confront the realities of increasing population sizes and corresponding food demands, the need for efficient and productive livestock systems becomes ever more pressing. Through the application of innovative genetic technologies, the potential to enhance food production systems while minimizing environmental impact is now within reach.

In conclusion, this meticulously conducted research not only advances our understanding of genomic predictions in pigs but lays the groundwork for future innovations in the field. The integration of multi-population data and the application of prior knowledge are powerful tools that spell the future of animal breeding. As the agricultural sector adapts to modern challenges, the approaches identified in this study will undoubtedly play a vital role in shaping sustainable livestock practices worldwide.

The findings of Wang et al. (2025) present a bright future for genomic applications in agriculture. By continuing to explore collaborations in genomic research and enhancing predictive technologies, the future of livestock genetics looks hopeful, paving the way for scientific advancements that will benefit both producers and consumers alike.

Subject of Research: Improving genomic prediction in pigs by integrating multi-population data and prior knowledge.

Article Title: Improving genomic prediction in pigs by integrating multi-population data and prior knowledge.

Article References: Wang, J., Lu, Y., Zhang, W. et al. Improving genomic prediction in pigs by integrating multi-population data and prior knowledge. BMC Genomics 26, 779 (2025). https://doi.org/10.1186/s12864-025-12011-z

Image Credits: AI Generated

DOI: 10.1186/s12864-025-12011-z

Keywords: Genomic prediction, swine genetics, multi-population data, machine learning, breeding, livestock production, sustainability, agricultural technology.

The importance of non-human primate genomes in understanding human genetics cannot be overstated. These species share considerable genetic similarity with humans, making them invaluable for studying the complexities of genomic variations. The conventional methods employed for variant analysis have often been cumbersome and limited in scope. However, the refinement model proposed by Choi and colleagues promises a more precise, automated approach that could transform how researchers analyze genomic data.

Central to this model is its ability to leverage machine learning techniques to enhance the accuracy of variant calling in genomic sequences. Machine learning has revolutionized numerous fields, and its application in genomics marks a powerful step in computational biology. By training their model on extensive datasets of primate genomes, the researchers have been able to identify subtle variations that were previously overlooked by traditional methods. This is particularly crucial for understanding complexities arising from structural variants and single nucleotide polymorphisms (SNPs) that can significantly influence phenotypic expressions.

The methodology used in this research is noteworthy. The model employs a series of algorithms to sift through vast genomic datasets, classifying variants based on their potential biological impacts and evolutionary significance. This twofold approach not only improves the identification of variants but also contextualizes their relevance within a broader biological framework. By implementing this refinement model, researchers can prioritize which variants warrant further investigation, thereby streamlining the research workflow.

Moreover, the study illustrates how this model has significant implications for evolutionary studies. By analyzing genetic variations across different non-human primate species, researchers can gain insights into evolutionary processes that have taken place over millions of years. This can lead to a deeper understanding of the genetic underpinnings of traits that are shared among these species, as well as traits that are unique to each branch of the primate lineage. Such insights hold promise for illuminating the pathways of human evolution.

Another facet of this refinement model is its potential application in medical research. Many human diseases are linked to genetic variations that may be present in non-human primate genomes. The ability to accurately characterize these variants allows researchers to explore potential models for human diseases, as well as develop therapeutic strategies based on this comparative genomics approach. For instance, identifying disease susceptibility genes in primates can lead to better predictive models and treatments for similar conditions in humans.

One of the standout features of the research is its adaptability. The model can be applied to various primate genomes, from cercopithecoids (Old World monkeys) to hominoids (apes), demonstrating versatility in its underlying algorithms. This adaptability also extends to the inclusion of diverse populations within these species, thereby accentuating its relevance in understanding not only the standard genetic makeup but also the implications of genetic diversity.

As this research makes its way through peer review and eventually into the broader scientific community, the implications of the findings are immense. The refinement model could establish a new standard for genomic variant analysis, incrementally shifting the methodologies with which researchers have approached the study of genomes. Furthermore, it could streamline future research endeavors, saving time and resources while producing more significant and reliable results.

In the context of advancements in genomics, this study reminds us of the relentless march toward understanding the human genome’s intricacies. As we unlock the codes of our closest genetic relatives, we stand on the brink of discoveries that could redefine our understanding of health, evolution, and what it means to be human in the grand tapestry of life.

The potential trajectories derived from this refinement model extend into various scientific domains. From conservation biology, where understanding genetic diversity can aid in species preservation efforts, to agricultural sciences that seek to enhance crop resilience through insights gained from primate genomics—this research holds the promise of a multitude of applications.

Furthermore, the deployment of such models underscores the increasing synergy between biology and computational sciences. As computational capabilities expand, the intersection between these fields continues to deepen, ushering in an era where complex biological questions can be addressed with unprecedented precision. The tools of the digital age, when married with biological inquiry, have the power to transform not just individual fields but the entirety of scientific investigation.

In conclusion, the work of Choi, Zhou, and Song marks a pivotal moment in the analysis of primate genomes. Their innovative refinement model stands to reshape the landscape of genetic variant analysis, paving the way for future research that could elucidate our understanding of both primate and human biology. As this research garners attention, it serves as a reminder of the endless possibilities that lie at the frontier of genetic exploration.

With the potential to unlock a treasure trove of biological insights, this study exemplifies the shift towards a more informed, data-driven future in genetic research. As we continue to explore the complexities of genomes, the implications of these findings will resonate throughout the fields of genomics, evolutionary biology, and medicine for years to come.

Subject of Research: Variant analysis in non-human primate genomes

Article Title: Learning a refinement model for variant analysis in non-human primate genomes

Article References:

Choi, J., Zhou, B. & Song, G. Learning a refinement model for variant analysis in non-human primate genomes.
BMC Genomics 26, 775 (2025). https://doi.org/10.1186/s12864-025-11921-2

Image Credits: AI Generated

DOI: 10.1186/s12864-025-11921-2

Keywords: genomic variant analysis, non-human primates, machine learning, evolutionary biology, genetic diversity, comparative genomics

The study, published in the esteemed journal Genetics in Medicine, offers the first data-driven approach to harmonizing the selection of genes for NBSeq programs worldwide. The researchers harnessed advanced machine learning techniques to distill complex patterns from an extensive dataset comprising thousands of genes selected by diverse screening programs. This methodological innovation presents a transformative tool capable of guiding policymakers and clinicians through the multifaceted decision-making process inherent in genomic newborn screening, ensuring that gene inclusion reflects not only scientific rigor but also practical considerations relevant to public health.

Central to the research is the observation that despite 27 NBSeq programs collectively analyzing 4,390 unique genes, only a small subset — precisely 74 genes, or about 1.7% — appear consistently in over 80% of these initiatives. This stark disparity reveals the heterogeneity in how different programs define clinical utility, evidence strength, and public health value when curating their gene panels. Such inconsistency poses a significant barrier to creating unified standards that could facilitate broader adoption, equitable access, and interpretable results for families worldwide.

The study identifies key predictors that strongly influence whether a gene is included in NBSeq panels. Among these, the presence of a gene-associated condition on the U.S. Recommended Uniform Screening Panel (RUSP) emerged as a top determinant. This reflects the weight of preexisting public health frameworks that prioritize conditions with established newborn screening protocols. Moreover, the availability of robust natural history data—a comprehensive understanding of the disease trajectory in the absence of intervention—is a crucial factor. Equally important is the demonstration of effective treatments, which validates the clinical actionability of detecting the gene variant in newborns.

To translate these insights into a practical tool for global NBSeq governance, the research team developed a sophisticated machine learning model incorporating 13 distinct predictors encompassing clinical, epidemiological, and therapeutic evidence metrics. This model achieved high accuracy in recreating gene selection patterns across existing programs, suggesting its capacity to reliably predict gene candidacy for inclusion. Importantly, the model’s adaptability permits continuous refinement as new genetic discoveries, treatment modalities, and regional health priorities emerge, fostering dynamic and evidence-responsive screening frameworks.

The implications of this research resonate profoundly within the precision medicine and public health communities. By providing a transparent and data-driven gene prioritization strategy, this tool could serve as a foundation for harmonizing NBSeq efforts internationally. Such harmonization is pivotal not only for scientific consistency but also for addressing ethical, legal, and social issues surrounding the return of genomic information in newborns, such as equity of access, informed consent, and the management of uncertain findings.

Moreover, the involvement of the International Consortium of Newborn Sequencing (ICoNS)—founded by leading figures in the field including Dr. Robert C. Green of Mass General Brigham and Dr. David Bick of Genomics England—anchors this publication in a global collaborative framework. ICoNS embodies the international effort to consolidate expertise, data, and policy perspectives to navigate the complex landscape of genomic newborn screening. The consortium’s commitment reflects the growing recognition that tackling genetic disorders at birth requires coordinated action transcending borders.

The use of machine learning in this context exemplifies a broader trend in biomedical research, leveraging computational intelligence to manage large-scale genomics data and extract actionable insights. Traditional gene selection processes for newborn screening have often relied on expert panels and consensus, which, while invaluable, may be limited by subjective biases and knowledge gaps. The data-driven approach demonstrated here underscores how quantitative methods can augment human expertise, enabling more transparent, scalable, and reproducible decision-making.

Importantly, this new model also allows for regional customization, acknowledging that genetic disorder prevalence, healthcare infrastructure, and treatment availability vary globally. This flexibility ensures that NBSeq programs are not only scientifically grounded but also contextually appropriate, thereby maximizing their clinical relevance and cost-effectiveness. Policymakers and healthcare providers can thus tailor screening panels to optimally serve their populations while maintaining core standards informed by robust evidence.

The study’s findings also highlight the challenges ahead. The vast majority of genes included in NBSeq programs lack consensus inclusion, reflecting ongoing uncertainty about their clinical significance, returns on investment, and ethical considerations related to possible overdiagnosis or incidental findings. Efforts to expand newborn genomic screening must therefore proceed cautiously, balancing innovation with responsible stewardship to protect the best interests of infants and their families.

Furthermore, as treatments for genetic disorders proliferate—driven by advances in gene therapy, enzyme replacement, and personalized medicine—the pressure to incorporate newly actionable genes into NBSeq panels will grow. The proposed machine learning framework equips stakeholders with a scalable mechanism to evaluate emerging candidates swiftly and systematically, avoiding fragmented rollouts and ensuring equitable access to cutting-edge interventions.

In summary, the Mass General Brigham-led study marks a milestone in advancing genomic newborn screening from disparate pilot projects toward a harmonized, evidence-based global initiative. By leveraging computational modeling and international collaboration, this work lays the foundation for a future where newborn screening programs are consistent, scientifically validated, and responsive to evolving medical knowledge. Such progress promises to enhance the early detection and treatment of genetic disorders, ultimately improving health outcomes from the very start of life.

Subject of Research: Genetic disorders consideration and gene selection for genomic newborn screening programs using machine learning.

Article Title: Data-driven consideration of genetic disorders for global genomic newborn screening programs

News Publication Date: 9-May-2025

Web References:

• Genetics in Medicine Article
• BabySeq Project
• Mass General Brigham Press Releases
• Mass General Brigham DNA Sequencing Study

References:
Minten T, et al. “Data-driven consideration of genetic disorders for global genomic newborn screening programs” Genetics in Medicine. DOI: 10.1016/j.gim.2025.101443

Keywords: Human genetics, genomic newborn screening, machine learning, genetic disorders, public health genomics, gene panel prioritization, precision medicine, newborn care, international collaboration

At the core of this development is Arc’s commitment to producing and openly sharing datasets of unparalleled scale and quality. The fusion of Arc’s deep expertise in biological systems with the cutting-edge single-cell sequencing and analysis technologies from 10x Genomics and Ultima Genomics heralds a new era in biological research where data acquisition is not only faster and more scalable but also immensely cost-effective. This synergy is central to pushing the boundaries of what is possible in biological modeling, enabling machine learning algorithms to generate predictive, mechanistic insights into cell behavior under various perturbational conditions.

10x Genomics contributes its state-of-the-art single-cell analysis platforms, notably the chromium Flex system endowed with the GEM-X Flex technology. This platform allows researchers to interrogate millions of individual perturbed cells simultaneously, achieving a remarkable combination of high resolution, robust data fidelity, and affordability at an unprecedented scale. The ability to handle such enormous sample throughput radically enhances the statistical power of experiments, accelerating discoveries in immunology, oncology, and neuroscience by capturing the subtle nuances of cellular responses and heterogeneity with single-cell precision.

The sequencing side of this groundbreaking approach is fortified by Ultima Genomics’ revolutionary UG100 sequencing system equipped with Solaris chemistry. Unlike conventional sequencing solutions, Ultima’s wafer-based technology and novel chemistry significantly lower per-base sequencing costs while boosting throughput and overall data quality. When integrated with 10x Genomics’ single-cell capture strategies, the UG100 platform’s performance ensures that large perturbational datasets can be generated efficiently, reliably, and at scale — an essential prerequisite for pushing virtual cell atlasing far beyond current resource limits.

Moreover, the UG100 Solaris Boost mode, available in early access, promises to further elevate data yield, allowing Arc to expedite its data generation pipeline as the Virtual Cell Atlas expands. This high-throughput mode represents a critical advancement in sequencing technology, tackling the historical tradeoffs between data depth, breadth, and cost. Such technological leaps are vital in enabling multi-dimensional profiling of millions of cells during various perturbations, providing a comprehensive roadmap of cellular states to fuel data-driven biological modeling and therapeutic hypothesis testing.

Leaders from all three institutions emphasize that their combined technologies and vision underpin a transformational shift toward building predictive “world models” of cellular function. Rather than relying on traditional guess-and-check experimental frameworks, which are often laborious and time consuming, these models leverage vast, perturbational single-cell datasets to simulate and predict how specific interventions might restore diseased cells to healthy states. This approach fundamentally changes the landscape of preclinical research and drug development by focusing resources on the most promising mechanistic hypotheses, thereby accelerating translational impact.

The Arc Institute, headquartered in Palo Alto, California, operates as an independent nonprofit research organization dedicated to pushing scientific boundaries through curiosity-driven investigations and interdisciplinary collaboration. Its Virtual Cell Atlas serves as a foundational resource for the scientific community, designed to catalyze innovation by providing open access to richly annotated single-cell perturbation datasets. The project is envisioned to be a long-term platform to underpin AI-driven models that transform biological understanding and enable precision therapeutics development.

From 10x Genomics, CEO Serge Saxonov highlighted the disruptive potential of GEM-X Flex technology for biological modeling. By delivering scalable, high-quality single-cell data at a cost structure accessible to broad scientific consortia, this platform empowers more ambitious experimental designs that integrate large sample sizes and intricate perturbational schemes. This democratization of single-cell sequencing infrastructure is critical to unlocking new frontiers in systems biology and personalized medicine.

Similarly, Gilad Almogy, Founder and Chief Executive Officer of Ultima Genomics, underscored how their sequencing architecture was purpose-built to surmount the cost and scalability limitations of legacy sequencing technologies. By enabling high-throughput, low-cost sequencing without sacrificing data integrity, Ultima fuels the generation of comprehensive datasets necessary for next-generation AI and machine learning applications in biology. Their collaboration with Arc and 10x Genomics exemplifies how technological innovation can coalesce around pressing scientific challenges, driving rapid progress.

Beyond technology, this collaborative effort highlights the scientific imperative to build integrated resources combining single-cell data from diverse sources, expanding the scope and resolution of perturbational atlases. The collective vision unites researchers aiming to refine predictive biological models that not only elucidate disease mechanisms but also guide the discovery of novel therapeutic strategies by simulating the effects of interventions at the cellular level.

One of the principal investigators at Arc, Patrick Hsu, noted the profound shift this initiative represents. By moving away from iterative, trial-based experimentation toward predictive models grounded in multi-million cell datasets, scientists can more efficiently identify key perturbations that revert pathological cells to healthy phenotypes. This model-driven experimental design paradigm holds promise to accelerate drug discovery timelines and inform clinical strategies with unmatched precision.

In sum, the partnership between Arc Institute, 10x Genomics, and Ultima Genomics encapsulates a major inflection point for biology, sequencing, and data science convergence. Their collective innovations in single-cell capture, ultra-high-throughput sequencing, and advanced perturbation data generation set the stage for virtual cell atlases that will become pivotal in the era of AI-driven biomedical research. As the datasets grow in size, quality, and accessibility, they will empower a new generation of computational tools and models capable of unraveling biological complexity and delivering targeted, mechanism-based therapies for complex diseases.

Scientists, clinicians, and researchers interested in exploring the Arc Virtual Cell Atlas and utilizing these rich perturbational datasets can access the resource at https://arcinstitute.org/tools/virtualcellatlas. This portal promises to be a nexus of collaborative discovery where unprecedented volumes of single-cell data inform next-generation biological models, potentially transforming medicine and health outcomes worldwide.

Subject of Research: Generation and utilization of large-scale perturbational single-cell data for predictive modeling of cellular states.

Article Title: Arc Institute, 10x Genomics, and Ultima Genomics Collaborate to Scale High-Resolution Single-Cell Perturbation Data for Virtual Cell Atlas Expansion.

Web References:

• Arc Virtual Cell Atlas: https://arcinstitute.org/tools/virtualcellatlas
• 10x Genomics: https://www.10xgenomics.com/
• Ultima Genomics: http://www.ultimagenomics.com/

Image Credits: Arc Institute, 10x Genomics, Ultima Genomics

Keywords: Scientific data, single-cell sequencing, perturbational data, virtual cell atlas, genomic technologies, biological modeling, AI in biology, high-throughput sequencing, single-cell analysis, computational biology, genomics, cell state perturbations